期刊文献+

鼻咽癌放疗后第二原发舌癌的临床分析

Clinical analysis of second primary tongue carcinoma after radiotherapy for nasopharyngeal cancer
下载PDF
导出
摘要 目的探讨鼻咽癌放疗后出现的第二原发舌癌的临床特点及其影响预后因素。方法对均为低分化鳞癌的鼻咽癌放疗后第二原发性舌癌29例患者行手术或包含手术的综合治疗、放疗、化疗,分析其影响因素及治疗预后。结果 29例患者总的3、5年生存率分别为51.7%(15/29)和37.9%(11/29),淋巴结转移率为13.79%(4/29);其中患者之间不同的性别、第二原发癌发病的年龄和两癌发病的间隔时间对患者的预后均无显著的影响,而不同的第二原发癌TNM分期及治疗方式对其预后有重要影响。结论鼻咽癌放疗后第二原发舌癌淋巴转移率较低;治疗方法和TNM分期是影响预后的因素;放射诱发的第二原发性舌癌如具备手术适应证,则应首选手术或包含手术的综合治疗,积极治疗第二原发性舌癌可以获得较好的效果。 Objective To investigate the clinical characteristics and prognosis of second primary tongue carcinoma after nasopharyngeal carcinoma radiotherapy. Methods 29 cases with second primary tongue carcinoma "after nasopharyngeal poorly differentiated squamous cell carcinoma radiotherapy, receiving surgery, followed by post-operative radio-chemotherapy were analyzed retrospectively. Results Of 29 patients, the overall 3-and 5-year survival rates were 51.7% and 37.9% respectively, and the lymph node metastasis rate was 13.79%. Sex, second primary cancer onset age and the interval between two cancers, had no significant influence on the survival, however the TNM staging of second primary cancer and its therapeutic methods showed significant influence on the prognosis. Conclusions The metastases rate of second primary tongue carcinoma after nasopharyngeal carcinoma radiotherapy is low. Both the treatment methods and the TNM staging may affect the prognosis. The second primary tongue cancer induced by radiation should be treated by surgery as the first option, or receive comprehensive treatment including surgery. Aggressive treatment of secondary primary tongue cancer may achieve favorable prognosis.
出处 《微创医学》 2015年第5期580-582,共3页 Journal of Minimally Invasive Medicine
关键词 鼻咽癌放疗 第二原发癌 舌癌 Nasopharyngeal carcinoma after radiotherapy Second primary tumors Tongue cancer Analyze
  • 相关文献

参考文献9

二级参考文献43

  • 1王天铎,卢永田.头颈部重复癌[J].山东医科大学学报,1994,32(3):243-246. 被引量:7
  • 2WARREN S,GATES Q.Muhiple primary malignant tumors A survey of the literature and a statistical study[J]. Am J Cancer,1932,16:1358-1414.
  • 3STURGIS EM, MILLER RH. Second primary malignancies in the head and neck cancer patients[J]. Ann Rhinal Otol Laryngol, 1955,104:946-954.
  • 4SLAUGHTER DP, SOUTHWICK HW,SMEJKAL W. “Field cancerization” in oral stratified epithelium: clinical implications of multi-centric origin[J]. Cancer,1953,6:963-968.
  • 5Warren S,Gates O.Multiple primary malignant tumors:a survey of the literature and a statistical study.Am J Cancer,1932,16:1358-1414.
  • 6Slaughter DP,Southwick HW,Smejkal W.Field caneerization in oral stratified squamous epithelium; clinical implications of multicentric origin.Cancer,1953,6:963-968.
  • 7Hashihe M,Ritz B,Le AD,et al.radiotherapy for oral cancer as a risk factor for second primary cancers.Cancer Lett,2005,220:185-195.
  • 8Chauveinc L,Mosseri V,Quintana E,et al.Osteosarcoma following retinohlastoma:age at onset and latency period.Ophthalmic Genet,2001.22:77-88.
  • 9Rennemo E,Zatterstr(o)m U,Evensen J,et al.Reduced risk of head and neck second primary tumors after radiotherapy.Radiother Oncol,2009,93:559-562.
  • 10Yamanoto E,Shihuya H,Yoshimura R,et al.Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma.Cancer,2002,94:2007-2014.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部